Cargando…
Neoantigens in precision cancer immunotherapy: from identification to clinical applications
Immunotherapies targeting cancer neoantigens are safe, effective, and precise. Neoantigens can be identified mainly by genomic techniques such as next-generation sequencing and high-throughput single-cell sequencing; proteomic techniques such as mass spectrometry; and bioinformatics tools based on h...
Autores principales: | Zhang, Qiao, Jia, Qingzhu, Zhang, Jing, Zhu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433083/ https://www.ncbi.nlm.nih.gov/pubmed/35838545 http://dx.doi.org/10.1097/CM9.0000000000002181 |
Ejemplares similares
-
Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
por: Okada, Masahiro, et al.
Publicado: (2022) -
Targeting neoantigens for cancer immunotherapy
por: Zhao, Xuan, et al.
Publicado: (2021) -
Tumor neoantigens: Novel strategies for application of cancer immunotherapy
por: GUAN, HANYANG, et al.
Publicado: (2023) -
Identification and Targeting of Mutant Peptide Neoantigens in Cancer Immunotherapy
por: Verdon, Daniel J., et al.
Publicado: (2021) -
Neoantigens and their potential applications in tumor immunotherapy
por: Fang, Xianzhu, et al.
Publicado: (2022)